Satoshi Nakahara

Kumamoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Lemborexant-induced interstitial lung disease: A case report.

Lemborexant-induced interstitial lung disease: A case report.

Journal: Respirology case reports

Published: February 15, 2024

Future prospects for cancer immunotherapy using induced pluripotent stem cell-derived dendritic cells or macrophages.

Future prospects for cancer immunotherapy using induced pluripotent stem cell-derived dendritic cells or macrophages.

Journal: Experimental dermatology

Published: November 17, 2022

Immunotherapy with 4-1BBL-Expressing iPS Cell-Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma.

Immunotherapy with 4-1BBL-Expressing iPS Cell-Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma.

Journal: International journal of molecular sciences

Published: January 06, 2021

Immune cell therapy against disseminated melanoma by utilizing induced pluripotent stem cell-derived myeloid cell lines producing interferon-beta or interleukin-15/interleukin-15 receptor alpha.

Immune cell therapy against disseminated melanoma by utilizing induced pluripotent stem cell-derived myeloid cell lines producing interferon-beta or interleukin-15/interleukin-15 receptor alpha.

Journal: Journal of dermatological science

Published: November 21, 2020

Serious disseminated intravascular coagulation associated with combination therapy of nivolumab and ipilimumab in advanced melanoma.

Serious disseminated intravascular coagulation associated with combination therapy of nivolumab and ipilimumab in advanced melanoma.

Journal: The Journal of dermatology

Published: April 11, 2020

Induced pluripotent stem cell-derived myeloid cells expressing OX40 ligand amplify antigen-specific T cells in advanced melanoma.

Induced pluripotent stem cell-derived myeloid cells expressing OX40 ligand amplify antigen-specific T cells in advanced melanoma.

Journal: Pigment cell & melanoma research

Published: June 13, 2019

MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma.

MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma.

Journal: Journal of dermatological science

Published: May 09, 2019

Nivolumab-induced colitis in a patient with malignant melanoma: A case report and immunological analysis.

Nivolumab-induced colitis in a patient with malignant melanoma: A case report and immunological analysis.

Journal: The Journal of dermatology

Published: March 26, 2019

Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma.

Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma.

Journal: Journal of dermatological science

Published: January 31, 2018

Achieved good response of S-1 and docetaxel combination chemotherapy in two patients with metastatic extramammary Paget's disease.

Achieved good response of S-1 and docetaxel combination chemotherapy in two patients with metastatic extramammary Paget's disease.

Journal: The Journal of dermatology

Published: November 25, 2016

AT-rich Interaction Domain-containing Protein 3B is a New Tumour Marker for Melanoma.

AT-rich Interaction Domain-containing Protein 3B is a New Tumour Marker for Melanoma.

Journal: Acta dermato-venereologica

Published: May 04, 2016

Cell division cycle-associated protein 1 as a new melanoma-associated antigen.

Cell division cycle-associated protein 1 as a new melanoma-associated antigen.

Journal: The Journal of dermatology

Published: December 16, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026